Home
Journals
Archaeology International
Architecture_MPS
Europe and the World: A law review
Film Education Journal
History Education Research Journal
International Journal of Development Education and Global Learning
International Journal of Social Pedagogy
Jewish Historical Studies: A Journal of English-Speaking Jewry
Journal of Bentham Studies
London Review of Education
Radical Americas
Research for All
The Journal of the Sylvia Townsend Warner Society
The London Journal of Canadian Studies
About
About UCL Press
Who we are
Contact us
My ScienceOpen
Sign in
Register
Dashboard
Search
Home
Journals
Archaeology International
Architecture_MPS
Europe and the World: A law review
Film Education Journal
History Education Research Journal
International Journal of Development Education and Global Learning
International Journal of Social Pedagogy
Jewish Historical Studies: A Journal of English-Speaking Jewry
Journal of Bentham Studies
London Review of Education
Radical Americas
Research for All
The Journal of the Sylvia Townsend Warner Society
The London Journal of Canadian Studies
About
About UCL Press
Who we are
Contact us
My ScienceOpen
Sign in
Register
Dashboard
Search
0
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,661
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Trodelvy (sacituzumab govitecan-hziy) [package insert].
Author(s):
Publication date:
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Stroke: Karger Topic Article Package
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
1,661
1219 Nonclinical safety evaluation of sacituzumab govitecan, a TROP-2-directed antibody drug conjugate (ADC), for non-muscle invasive bladder cancer
Authors:
Carrie McMahon
,
Lauri Diehl
,
Laurie Tatalick
…
Final Results from TROPHY-U-01 Cohort 1: A Phase 2 Open-Label Study of Sacituzumab Govitecan (SG) in Patients with Metastatic Urothelial Cancer (mUC) and Disease Progression after Platinum (PLT)-Based Regimens and Checkpoint Inhibitors
Authors:
Y Loriot
,
A.V. Balar
,
D.P. Petrylak
…
Single-arm, phase II study to evaluate the safety and efficacy of sacituzumab govitecan in patients with metastatic castration-resistant prostate cancer who have progressed on second generation AR-directed therapy.
Authors:
Joshua Lang
,
Christos P. Kyriakopoulos
,
Susan F. Slovin
…
See all similar
Cited by
1
Breast Cancer Immunotherapy: A Clinical Review for the Plastic Surgeon
Authors:
Matthew J. Heron
,
Katherine J. Zhu
,
Lily Zhu
…
See all cited by